P1-(5'-adenosyl)-P2-N-(2-mercaptoethyl)diphosphoramidate. An affinity reagent for demonstrating the presence of Tyr-beta 311 at the hydrolytic site of F1-ATPase.

The compound P1-(5'-adenosyl)-P2-N-(2-mercaptoethyl)diphosphoramidate (AMEDA) was synthesized as an ATP analogue for in situ reaction with the 4-nitro-2,1,3-[14C]benzoxadiazolyl group (NBD) in the labeled F1-ATPase (F1). AMEDA was found to reactivate O-[14C]NBD-F1 via a dual-path mechanism. The principal path involves the binding of AMEDA at a site in F1 with Kd = 14.5 microM and subsequent reaction with the [14C]NBD label. The second slower path involves the direct biomolecular reaction of AMEDA with the radioactive label on F1. The rate of reactivation of O-[14C]NBD-F1 by AMEDA was decreased by ADP or ATP which competes with the ATP analogue for binding to the labeled enzyme. The reaction product was found to contain one adenine group, two phosphate groups, and one [14C]NBD label per molecule as expected from the structure of the compound AMEDA-[14C]NBD. Purified AMEDA-[14C]NBD was found to bind to unlabeled F1 with Kd = 2 microM. These observations demonstrate the in situ reaction of bound AMEDA with the nearby [14C]NBD label attached to Tyr-beta 311 and support the assumed presence of Tyr-beta 311 near the phosphate groups of ATP bound at the hydrolytic site of F1-ATPase. The possible locations of Tyr-beta 364, His-beta 427, and Tyr-beta 345 relative to Tyr-beta 311 in F1 are discussed, and the validity of the previously proposed model for F1-ATPase with one hydrolytic site assisted by two auxiliary sites is examined and compared with that of the widely accepted alternating sites model.